Gemmer Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Gemmer Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-92	Closed	-$5K	–	1491
2020 Q3	$5K	Hold	92	–	–	﹤0.01%	910
2020 Q2	$3K	Hold	92	–	–	﹤0.01%	1116
2020 Q1	$3K	Buy	+92	New	+$2.56K	﹤0.01%	1006
2019 Q1	–	Sell	-186	Closed	-$2K	–	1453
2018 Q4	$2K	Buy	+186	New	+$2.59K	﹤0.01%	1266
2015 Q1	–	Sell	-245	Closed	-$3K	–	1440
2014 Q4	$3K	Sell	245 -53	-18%	-$606	﹤0.01%	1084
2014 Q3	$3K	Buy	298 +243	+442%	+$2.77K	﹤0.01%	1080
2014 Q2	$1K	Sell	55 -41	-43%	-$484	﹤0.01%	1363
2014 Q1	$1K	Buy	+96	New	+$1.63K	﹤0.01%	1350

Gemmer Asset Management's MNTA Position: Q4 2020 in Review

Gemmer Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 92 shares — an estimated $5K sold.

Gemmer Asset Management first reported a position in MNTA in Q1 2014 and held it in 8 quarters. The position peaked at $5K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Gemmer Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Gemmer Asset Management sold 92 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5K.
Gemmer Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 8 quarters.
Gemmer Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $5K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Gemmer Asset Management's 13F filing for Q4 2020, filed 28 Jan 2021.